Disease specific expression pattern of NOX4 isoforms may provide new diagnostic and therapeutic targets in heart failure, and disease-specific splicing events might represent a new factor to consider when developing NOX4-modulator drugs. This evidence concerns the gene NOX4 and heart failure.